| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.STR.18.1.257 |
| P698 | PubMed publication ID | 3101233 |
| P2093 | author name string | S R Levine | |
| K M Welch | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anticoagulation | Q63279445 |
| anticoagulant | Q215118 | ||
| P304 | page(s) | 257-263 | |
| P577 | publication date | 1987-01-01 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Cerebrovascular ischemia associated with lupus anticoagulant | |
| P478 | volume | 18 |
| Q93515633 | Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases |
| Q28196376 | Acquired thrombophilias and pregnancy |
| Q34530795 | Amaurosis fugax associated with antiphospholipid antibodies |
| Q70755530 | Antiphospholipid antibodies syndrome and cerebral ischemia |
| Q48295399 | Cardioembolic caudate infarction as a cause of hemichorea in lupus anticoagulant syndrome |
| Q43573085 | Cardiogenic brain embolism and lupus anticoagulant |
| Q37811603 | Cutaneous thrombosis, cerebrovascular thrombosis, and lupus anticoagulant--the Sneddon syndrome. Report of 10 cases |
| Q31166031 | Diagnosis and pathogenesis of CNS lupus |
| Q33379907 | Immunology and Clinical Importance of Antiphospholipid Antibodies |
| Q33564647 | Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum |
| Q33733186 | Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus |
| Q34057664 | Long-term follow-up of ischaemic retinopathy in the antiphospholipid syndrome with lupus-like disease |
| Q43731338 | Magnetic resonance imaging findings in lupus ataxia |
| Q34354754 | Management of pregnancy in antiphospholipid syndrome |
| Q48616813 | Microangiopathy with retinopathy, encephalopathy, and deafness (RED-M) and systemic features |
| Q36070612 | Migraine and antiphospholipid antibodies |
| Q68066031 | Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids |
| Q43523516 | Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: clinical and immunological features |
| Q33498327 | Pathogenesis and treatment of the antiphospholipid antibody syndrome |
| Q36681618 | Prevalence of anticardiolipin antibodies in the elderly British population |
| Q86527461 | Prevention of recurrent stroke in patients with systemic lupus erythematosus or lupus anticoagulant |
| Q43446662 | Primary antiphospholipid syndrome (PAPS). Two case reports and therapeutic implications |
| Q70151123 | Retinal migraine, chorea, and retinal artery thrombosis in a patient with primary antiphospholipid antibody syndrome |
| Q34195498 | Stroke in young people--the heart of the matter |
| Q56429309 | Transient monocular blindness |
| Q33939249 | Transient visual symptoms in systemic lupus erythematosus and antiphospholipid syndrome |
| Q71992286 | Treatment of the antiphospholipid syndrome |
| Q69961748 | Vascular headache: a presenting symptom of multiple sclerosis |
| Q70406514 | Visual symptoms associated with the presence of a lupus anticoagulant |
Search more.